BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

701 related articles for article (PubMed ID: 18056756)

  • 1. Modulation of established murine collagen-induced arthritis by a single inoculation of short-term lipopolysaccharide-stimulated dendritic cells.
    Salazar L; Aravena O; Abello P; Escobar A; Contreras-Levicoy J; Rojas-Colonelli N; Catalán D; Aguirre A; Zúñiga R; Pesce B; González C; Cepeda R; Cuchacovich M; Molina MC; Salazar-Onfray F; Delgado M; Toes RE; Aguillón JC
    Ann Rheum Dis; 2008 Sep; 67(9):1235-41. PubMed ID: 18056756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term lipopolysaccharide stimulation induces differentiation of murine bone marrow-derived dendritic cells into a tolerogenic phenotype.
    Salazar L; Aravena O; Contreras-Levicoy J; Pesce B; Catalan D; Zuniga R; Iruretagoyena M; Kalergis AM; Aguillón JC
    Eur Cytokine Netw; 2007 Jun; 18(2):78-85. PubMed ID: 17594940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen-specific immunomodulation of collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells.
    van Duivenvoorde LM; Louis-Plence P; Apparailly F; van der Voort EI; Huizinga TW; Jorgensen C; Toes RE
    Arthritis Rheum; 2004 Oct; 50(10):3354-64. PubMed ID: 15476255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone preconditioning improves the response of collagen-induced arthritis to treatment with short-term lipopolysaccharide-stimulated collagen-loaded dendritic cells.
    Peña C; Gárate D; Contreras-Levicoy J; Aravena O; Catalán D; Aguillón JC
    Clin Dev Immunol; 2013; 2013():296031. PubMed ID: 23818913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis.
    Min SY; Park KS; Cho ML; Kang JW; Cho YG; Hwang SY; Park MJ; Yoon CH; Min JK; Lee SH; Park SH; Kim HY
    Arthritis Rheum; 2006 Mar; 54(3):887-98. PubMed ID: 16508971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8alpha+ dendritic cells enhance the antigen-specific CD4+ T-cell response and accelerate development of collagen-induced arthritis.
    Jung YO; Min SY; Cho ML; Park MJ; Jeon JY; Lee JS; Oh HJ; Kang CM; Park HS; Park KS; Cho SG; Park SH; Kim HY
    Immunol Lett; 2007 Aug; 111(2):76-83. PubMed ID: 17610959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis.
    Kelchtermans H; Geboes L; Mitera T; Huskens D; Leclercq G; Matthys P
    Ann Rheum Dis; 2009 May; 68(5):744-50. PubMed ID: 18480308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role of M. tuberculosis for dendritic cell maturation to induce collagen-induced arthritis in H-2b background of C57BL/6 mice.
    Kai H; Shibuya K; Wang Y; Kameta H; Kameyama T; Tahara-Hanaoka S; Miyamoto A; Honda S; Matsumoto I; Koyama A; Sumida T; Shibuya A
    Immunology; 2006 Jun; 118(2):233-9. PubMed ID: 16771858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor receptor gene therapy affects cellular immune responses in collagen induced arthritis in mice.
    Mukherjee P; Yang SY; Wu B; Song Z; Myers LK; Robbins PD; Wooley PH
    Ann Rheum Dis; 2005 Nov; 64(11):1550-6. PubMed ID: 15860512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tolerance and OVA-induced tolerogenic dendritic cells reduce the severity of collagen/ovalbumin-induced arthritis in mice.
    Thomé R; Fernandes LG; Mineiro MF; Simioni PU; Joazeiro PP; Tamashiro WM
    Cell Immunol; 2012 Nov; 280(1):113-23. PubMed ID: 23298866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of lymphocytes with a Th1 cytokine profile in bone cell damage associated with MMP-9 production in collagen-induced arthritis.
    Chen J; Zhang XM; Xu Q
    Inflamm Res; 2004 Dec; 53(12):670-9. PubMed ID: 15654515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo.
    Jaen O; Rullé S; Bessis N; Zago A; Boissier MC; Falgarone G
    Immunology; 2009 Jan; 126(1):35-44. PubMed ID: 18754812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
    Strid J; Tan LA; Strobel S; Londei M; Callard R
    PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells.
    Zheng X; Suzuki M; Ichim TE; Zhang X; Sun H; Zhu F; Shunnar A; Garcia B; Inman RD; Min W
    J Immunol; 2010 Jun; 184(11):6457-64. PubMed ID: 20435931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 as a molecular target in immune-mediated arthritis: immunoregulatory properties of genetically modified murine dendritic cells that secrete interleukin-4.
    Sarkar S; Tesmer LA; Hindnavis V; Endres JL; Fox DA
    Arthritis Rheum; 2007 Jan; 56(1):89-100. PubMed ID: 17195211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist.
    Lamacchia C; Palmer G; Seemayer CA; Talabot-Ayer D; Gabay C
    Arthritis Rheum; 2010 Feb; 62(2):452-62. PubMed ID: 20112392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
    Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
    J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.